Nanovaccines empowering CD8 + T cells: a precision strategy to enhance cancer immunotherapy
Theranostics · 10.02.2025 · 15 (7) · 3098-3121
DOI: 10.7150/thno.107856 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, erschienen am 10.02.2025. Verfasst von Yunfan Lin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, 510280, Guangdong, China. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Neoplasms, Immunotherapy, Cancer Vaccines. Die Arbeit wurde bisher 30-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, 510280, Guangdong, China.
- Department of Dentistry, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
- School of Dentistry, University of California, Los Angeles, Los Angeles, 90095, CA, USA.
Zitieren
APA
Lin, Y., Lin, P., Xu, R., Chen, X., Lu, Y., Zheng, J., Zheng, Y., Zhou, Z., Mai, Z., Zhao, X., & Cui, L. (2025). Nanovaccines empowering CD8 + T cells: a precision strategy to enhance cancer immunotherapy. Theranostics, 15(7), 3098-3121. https://doi.org/10.7150/thno.107856
Vancouver
Lin Y, Lin P, Xu R, Chen X, Lu Y, Zheng J, et al. Nanovaccines empowering CD8 + T cells: a precision strategy to enhance cancer immunotherapy. Theranostics. 2025;15(7):3098-3121. doi:10.7150/thno.107856
BibTeX
@article{Lin2025,
author = {Lin, Yunfan and Lin, Pei and Xu, Rongwei and Chen, Xu and Lu, Ye and Zheng, Jiarong and Zheng, Yucheng and Zhou, Zihao and Mai, Zizhao and Zhao, Xinyuan and Cui, Li},
title = {Nanovaccines empowering CD8 + T cells: a precision strategy to enhance cancer immunotherapy},
journal = {Theranostics},
year = {2025},
volume = {15},
number = {7},
pages = {3098--3121},
doi = {10.7150/thno.107856}
}
EUVIMED